CPV subcategory
33696200: Blood-testing reagents
CPV code 33696200 is "Blood-testing reagents", a subcategory in the Common Procurement Vocabulary used to classify UK public sector contracts. It, or a more specific code beneath it, was used on 12 UK public contracts since 2023, awarded by 9 buyers, most often NHS Blood and Transplant and Yorkshire Ambulance Service NHS Trust. The typical contract was worth about £180k.
UK public contracts since 2023
How buyers use 33696200
- Contracts
- 12
- Buyers
- 9
- Typical value
- £180k
- Ending in 18 months
- 5
By year of award: 2023 1 · 2024 2 · 2025 6 · 2026 3. Figures as of 23 September 2026. Typical value is the median of single-supplier contracts with a published value (10).
Buyers using this code most
Suppliers winning most often
- Abbott Toxicology Limited2
- AB Scientific Limited2
- Critical Healthcare Limited2
- Alphabiolaboratories Analytical Limited (t/a AlphaBiolabs)1
- BHA Medical Limited1
- Eurofins Forensic Services Limited1
- Global Scientific Limited1
- IQVIA Ltd1
Recent contracts under 33696200
| Contract | Buyer | Value | Awarded |
|---|---|---|---|
| YAS 147 2026_27 (DA FW) Point of Care Test Equipment and Associated Products | Yorkshire Ambulance Service NHS Trust | £140k | Sept 2026 |
| LSL/MED/0212 - The Supply and Support of Blood Bank Centrifuge Devices | Leidos Supply Limited | £1.0m | Jul 2026 |
| Supply of 3rd Party Quality Controls | NHS Blood and Transplant | £167k | Jan 2026 |
| Microbiology & Serology Testing | NHS Blood and Transplant | Framework | Oct 2025 |
| Oncotype DX Breast recurrence score test | Leeds Teaching Hospital NHS Trust | £192k | Oct 2025 |
| YAS 163 2025_26 (DA FW) Point of Care Test Equipment and Associated Products | Yorkshire Ambulance Service NHS Trust | £140k | Oct 2025 |
| Drug and Alcohol Testing 25+ | Nuclear Restoration Services Limited | £243k | Sept 2025 |
| Commercial Kit for screening for hereditary tyrosinemia type 1 (HT1) | NHS England | £1.7m | Mar 2025 |
Where it sits
Codes above 33696200
- 33000000Medical equipments, pharmaceuticals and personal care products
- 33600000Pharmaceutical products
- 33690000Various medicinal products
- 33696000Reagents and contrast media
- 33696200Blood-testing reagents
See the whole market in medical equipment and pharmaceuticals contracts, with buyers, suppliers and contracts ending soon.
More specific
Codes beneath 33696200
None. 33696200 is as specific as the vocabulary goes for blood-testing reagents.
Questions
About CPV code 33696200
What is CPV code 33696200?
CPV code 33696200 is "Blood-testing reagents", a subcategory in the Common Procurement Vocabulary used to classify UK public sector contracts. It, or a more specific code beneath it, was used on 12 UK public contracts since 2023, awarded by 9 buyers, most often NHS Blood and Transplant and Yorkshire Ambulance Service NHS Trust. The typical contract was worth about £180k.
Which codes sit above and below 33696200?
33696200 sits under 33000000 (Medical equipments, pharmaceuticals and personal care products), then 33600000 (Pharmaceutical products), then 33690000 (Various medicinal products), then 33696000 (Reagents and contrast media). It has no more specific codes beneath it.
Who wins contracts under CPV code 33696200?
The suppliers named most often on UK public contracts under 33696200 since 2023 are Abbott Toxicology Limited (2), AB Scientific Limited (2), Critical Healthcare Limited (2). 23 different suppliers have won work under this code.
How do I get alerts for tenders using CPV code 33696200?
Add 33696200 to a Tender Radar profile, with keywords that describe your work. Each weekday morning you get the new UK public sector notices that match, scored for fit. Because codes cover the codes beneath them, adding 33696200 also catches notices classified under its more specific codes.
Get the tenders filed under 33696200
Tender Radar reads every new UK public sector notice each morning and emails you the ones that match your codes and keywords, scored for how well they fit. 30 days free.
30 days free. No card required to start.